Abstract

Leptospirosis is an infectious natural-focal disease of many species of animals and human with a wide range of clinical signs. The most common serovars causing leptospirosis in dogs are Icterohaemorrhagiae and Canicola. Analyzing the epizootic situation concerning leptospirosis of carnivores in Ukraine, employees of the Laboratory of Leptospirosis of Institute of Veterinary Medicine of the National Academy of Agrarian Sciences have developed and produced successively three series of bivalent inactivated vaccine against leptospirosis of carnivores, taking into account the etiological structure of the disease of this animal species. The paper presents the results of the study of three experimental series of inactivated polyvalent vaccine against leptospirosis of carnivores regarding: pH, sterility, residual amounts of inactivant, completeness of inactivation, harmlessness and immunogenic activity. It has been established that according to the indicators of sterility, completeness of inactivation, residual amount of inactivant, harmlessness and concentration of hydrogen ions, all three series of vaccine meet the requirements and norms of normative documentation. Intravenous administration of all three experimental series of the vaccine to the experimental rabbits provided the formation of specific anti-leptospirosis antibodies in the titers corresponding to the parameters of the immunogenicity norms established in the technical conditions of the drug.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.